CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
DS-3201b is an experimental drug. It is not approved for regular use. It can only be used in clinical research.Adults with non-Hodgkin lymphoma...
Phase 1
Philadelphia, Pennsylvania, United States and 20 other locations
Follicular lymphoma (FL), marginal zone lymphoma (MZL), and mantle cell lymphoma (MCL) are distinct histologic types of B-...
Phase 3
Mount Holly, New Jersey, United States and 125 other locations
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections). Classic...
Phase 2
Allentown, Pennsylvania, United States and 50 other locations
(R/R) chronic lymphocytic leukemia (CLL) and non-Hodgkin's lymphoma. However, single drug therapies have limitations, therefore, the current...
Phase 2
Philadelphia, Pennsylvania, United States and 7 other locations
TrAVeRse is a multicentre, open-label, randomised, Phase II study of AVR in treatment naïve MCL participants. The primary objective will be to assess...
Phase 2
Philadelphia, Pennsylvania, United States and 47 other locations
Of Care in adult patients with aggressive B-cell Non-Hodgkin Lymphoma after failure of rituximab and anthracycline containing frontline immu...
Phase 3
Philadelphia, Pennsylvania, United States and 66 other locations
treatment of advanced classical Hodgkin lymphoma(HL)...
Phase 3
Philadelphia, Pennsylvania, United States and 215 other locations
This study will characterize the safety and clinical benefit of valemetostat tosylate in participants with relapsed/refractory peripheral T-cell lymphoma...
Phase 2
Philadelphia, Pennsylvania, United States and 59 other locations
purpose of this study is to assess the objective response rate of parsaclisib treatment in participants with relapsed or refractory follicular lymphoma...
Phase 2
Philadelphia, Pennsylvania, United States and 82 other locations
The purpose of this study is to test the safety of abexinostat at different doses to find out if it can work with ibrutinib to stop the cancer from g...
Phase 1
Allentown, Pennsylvania, United States and 6 other locations
Clinical trials
Research sites
Resources
Legal